DRC Patent Breakdown

This episode of DRC Patent Breakdown explains Patent US-20170107111-A1 in plain English, focusing on how clinoptilolite was transformed from an insoluble mineral into water-soluble fragments designed for broader nutraceutical, pharmaceutical, and environmental applications.We walk through the core problem the patent aimed to solve, the hydrolysis/electrolysis/solvolysis process described in the filing, and why bioavailability is the key concept behind the invention. We also connect the patent to product applications associated with Clean Slate, Clean Spirits, Pure Clean Pets, and Coato while keeping the discussion accessible for general listeners.What clinoptilolite is and why its natural form has limitsHow the patent describes breaking it into smaller water-soluble fragmentsWhy the inventors believed that changed absorption and detox support potentialHow the technology was positioned across wellness and environmental use cases

This episode breaks down U.S. Patent 10,894,721 B2 in plain language and explains what makes Dr. Christina Rahm’s patented clinoptilolite process different from standard zeolite products. We focus on the patent’s core distinctions—water-soluble fragments, electrolyzed/solvolyzed processing, and broad formulation applications—while keeping the discussion educational and compliant.Listeners will hear how the patent helps explain the innovation behind products associated with this technology, including Clean Slate, Clean Spirits, Pure Clean Pets, and Coato, and why a patented process can matter when comparing product design, delivery format, and intended functionality.

This episode explains Patent US-20170107121-A1 in simple terms, focusing on how clinoptilolite is transformed from an insoluble mineral into water-soluble fragments through hydrolysis and electrolysis. We break down why that matters, what the patent claims, and how the technology is positioned for nutraceutical, pharmaceutical, and environmental use.Listeners will hear a clear overview of the core scientific idea, the detoxification and binding claims described in the patent, and the broader product and remediation applications connected to the invention.